The Longevity Fund

Investor type

VC

Founded

2011

AUM

$37 M

Location

San Francisco, California, United States

Investment Ticket

$1-5 m

Investment Stage

Seed Series A

Region of investment

North America Europe Asia
Investor profile last updated: 13 August, 2026

Profile

The Longevity Fund is a venture capital firm based in San Francisco, founded in 2011 by Laura Deming. They focus on investing in companies that aim to increase the healthy lifespan of humans through medical advancements, particularly targeting age-related diseases. The firm is known for backing pioneering companies in the longevity field and continues to support mission-oriented entrepreneurs with a passion for this emerging sector. Their team is dedicated to scouting and nurturing talent that can drive groundbreaking developments in longevity medicine.

The Longevity Fund invests in biotechnology, pharmaceuticals, and healthcare services, alongside other life sciences sectors. They focus on early-stage funding, primarily Series A, with investments typically ranging from $1-5 million. The firm operates globally but has a pronounced interest in companies with the potential to impact longevity sciences. They recently announced a new vehicle named the Age1 Fund, which will further explore innovative longevity solutions.

Notable investments from The Longevity Fund include companies like Unity Biotechnology - focusing on therapies for age-related diseases, and Precision Biosciences - an early-stage company in genome editing. They are recognized for nurturing founders who challenge the norm in biotech to develop transformative products in the healthcare industry.

Industry

Digital Biotechnology Healthcare Services Pharmaceuticals Life Sciences HealthTech

The Longevity Fund Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Age1 Fund
Venture Capital (VC)
Biotechnology
Healthcare Services
Pharmaceuticals
Life Sciences
HealthTech
Series A
North America
Europe
Asia
$1-5 m
—
September 2026

Contacts

Name
Title
Email
avatar
Laura Deming Partner
Partner
-
avatar
Lily Clayton Head of Operations
Head of Operations
-
Upgrade to see contacts
avatar
PpSfORoWjvU5MAJa PpSfORoWjvU5MAJa
PpSfORoWjvU5MAJa
avatar
PpSfORoWjvU5MAJa PpSfORoWjvU5MAJa
PpSfORoWjvU5MAJa
avatar
PpSfORoWjvU5MAJa PpSfORoWjvU5MAJa
PpSfORoWjvU5MAJa
Investment-team contacts for The Longevity Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about The Longevity Fund

The Longevity Fund is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $1-5 m.
The Longevity Fund is located in San Francisco, California, United States.
The Longevity Fund was founded in 2011.
The Longevity Fund invests in companies and startups in Digital, Biotechnology, Healthcare Services, Pharmaceuticals, Life Sciences, HealthTech.
The Longevity Fund invests in companies and startups in North America, Europe, Asia.
The Longevity Fund invests in companies and startups at Seed, Series A.
The Longevity Fund usually invests $1-5 m on average.
The Longevity Fund has around $37m assets under management.
The Longevity Fund can be reached through its website longevity.vc and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for The Longevity Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query The Longevity Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 13 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.